☆Catalio Capital Management, LP
Quality Q
0.061
AUM ($M)
532
Positions
39
Turnover
0.45
Top-10 wt
57%
Herfindahl
0.045
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 52 positions · portfolio value $532M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆AVLN funds › | AVALYN PHARMACEUTICALS INC | NEW | — | 10.4% | +10.4% | 55.2 | 1,675,830 | +1,675,830 | 1 | — |
| ☆JNJ funds › | JOHNSON & JOHNSON | NEW | — | 6.6% | +6.6% | 35.3 | 138,946 | +138,946 | 1 | — |
| ☆GILD funds › | GILEAD SCIENCES INC | ADD | — | 6.4% | +1.6% | 34.0 | 269,309 | +105,404 | 3 | — |
| ☆BBIO funds › | BRIDGEBIO PHARMA INC | ADD | — | 6.4% | -0.3% | 33.9 | 455,041 | +23,027 | 2 | — |
| ☆SNDX funds › | SYNDAX PHARMACEUTICALS INC | ADD | — | 5.0% | -0.1% | 26.6 | 1,215,698 | +172,028 | 5 | — |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | TRIM | — | 5.0% | +0.9% | 26.5 | 562,672 | -475,312 | 2 | — |
| ☆BMY funds › | BRISTOL-MYERS SQUIBB CO | TRIM | — | 4.5% | -0.9% | 23.8 | 412,961 | -7,766 | 3 | — |
| ☆PBLS funds › | PARABILIS MEDICINES INC | NEW | — | 4.2% | +4.2% | 22.6 | 824,043 | +824,043 | 1 | — |
| ☆NTRA funds › | NATERA INC | ADD | — | 4.2% | +1.2% | 22.3 | 82,181 | +11,274 | 5 | — |
| ☆INCY funds › | INCYTE CORP | ADD | — | 4.1% | +0.5% | 21.7 | 191,627 | +9,526 | 2 | — |
| ☆SEPN funds › | SEPTERNA INC | ADD | — | 3.4% | +1.9% | 18.0 | 536,152 | +241,792 | 5 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | ADD | — | 3.3% | +0.8% | 17.5 | 648,722 | +209,681 | 3 | — |
| ☆HTFL funds › | HEARTFLOW INC | ADD | — | 3.2% | +1.2% | 17.1 | 583,055 | +179,467 | 3 | — |
| ☆CRVS funds › | CORVUS PHARMACEUTICALS INC | ADD | — | 3.0% | +0.3% | 16.1 | 1,080,888 | +188,955 | 2 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | ADD | — | 2.8% | +0.2% | 14.8 | 276,550 | +21,171 | 5 | — |
| ☆PTGX funds › | PROTAGONIST THERAPEUTICS INC | NEW | — | 2.5% | +2.5% | 13.1 | 106,799 | +106,799 | 1 | — |
| ☆IRON funds › | DISC MEDICINE INC | ADD | — | 2.2% | +0.5% | 11.7 | 159,384 | +36,406 | 5 | — |
| ☆EW funds › | EDWARDS LIFESCIENCES CORP | TRIM | — | 2.1% | -0.3% | 11.3 | 124,778 | -19,829 | 3 | — |
| ☆AXSM funds › | AXSOME THERAPEUTICS INC. | NEW | — | 2.0% | +2.0% | 10.6 | 43,182 | +43,182 | 1 | — |
| ☆RARE funds › | ULTRAGENYX PHARMACEUTICAL IN | TRIM | — | 2.0% | -1.7% | 10.6 | 316,252 | -534,545 | 5 | — |
| ☆KLRA funds › | KAILERA THERAPEUTICS INC | NEW | — | 1.9% | +1.9% | 10.3 | 468,750 | +468,750 | 1 | — |
| ☆KPTI funds › | KARYOPHARM THERAPEUTICS INC | ADD | — | 1.7% | +0.7% | 9.2 | 940,855 | +43,146 | 5 | — |
| ☆ODTX funds › | ODYSSEY THERAPEUTICS INC | NEW | — | 1.6% | +1.6% | 8.6 | 457,839 | +457,839 | 1 | — |
| ☆ASND funds › | ASCENDIS PHARMA A/S | NEW | — | 1.6% | +1.6% | 8.5 | 31,759 | +31,759 | 1 | — |
| ☆KARD funds › | KARDIGAN INC | NEW | — | 1.4% | +1.4% | 7.5 | 312,500 | +312,500 | 1 | — |
| ☆ELDN funds › | ELEDON PHARMACEUTICALS INC | ADD | — | 1.3% | +0.2% | 6.7 | 1,695,071 | +55,255 | 4 | — |
| ☆FDMT funds › | 4D MOLECULAR THERAPEUTICS IN | NEW | — | 1.2% | +1.2% | 6.3 | 471,254 | +471,254 | 1 | — |
| ☆MANE funds › | VERADERMICS INC | TRIM | — | 1.1% | -1.2% | 5.6 | 45,856 | -127,726 | 2 | — |
| ☆DYN funds › | DYNE THERAPEUTICS INC | TRIM | — | 1.0% | -0.0% | 5.4 | 244,929 | -38,025 | 3 | — |
| ☆CUSIP:35168W103 funds › | FRACTYL HEALTH INC | ADD | — | 0.9% | +0.4% | 4.9 | 6,168,749 | +676,883 | 5 | — |
| ☆IMCR funds › | IMMUNOCORE HLDGS PLC | ADD | — | 0.9% | +0.4% | 4.7 | 148,045 | +63,693 | 2 | — |
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | TRIM | — | 0.6% | -9.2% | 3.2 | 32,941 | -527,367 | 5 | — |
| ☆BBOT funds › | BRIDGEBIO ONCOLOGY THERAPEUT | NEW | — | 0.5% | +0.5% | 2.4 | 318,407 | +318,407 | 1 | — |
| ☆TARA funds › | PROTARA THERAPEUTICS INC | TRIM | — | 0.4% | -0.3% | 2.0 | 520,148 | -59,876 | 5 | — |
| ☆HYPR funds › | HYPERFINE INC | HOLD | — | 0.3% | +0.0% | 1.8 | 1,320,041 | +0 | 5 | — |
| ☆ATAI funds › | ATAIBECKLEY INC | HOLD | — | 0.2% | +0.0% | 1.0 | 196,858 | +0 | 2 | — |
| ☆MGX funds › | METAGENOMI THERAPEUTICS INC | HOLD | — | 0.1% | -0.0% | 0.6 | 528,993 | +0 | 5 | — |
| ☆OM funds › | OUTSET MED INC | HOLD | — | 0.1% | +0.0% | 0.5 | 118,279 | +0 | 5 | — |
| ☆FTH funds › | FAETH THERAPEUTICS INC | HOLD | — | 0.1% | -0.0% | 0.4 | 14,718 | +0 | 5 | — |
| ☆PHAT funds › | PHATHOM PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -247,767 | 0 | — |
| ☆CUSIP:483497103 funds › | KALVISTA PHARMACEUTICALS INC | EXIT | — | 0.0% | -1.8% | 0.0 | 0 | -426,551 | 0 | — |
| ☆NAMS funds › | NEWAMSTERDAM PHARMA COMPANY | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -83,554 | 0 | — |
| ☆CYTK funds › | CYTOKINETICS INC | EXIT | — | 0.0% | -3.0% | 0.0 | 0 | -215,501 | 0 | — |
| ☆CUSIP:834203309 funds › | SOLENO THERAPEUTICS INC | EXIT | — | 0.0% | -4.0% | 0.0 | 0 | -577,808 | 0 | — |
| ☆BSX funds › | BOSTON SCIENTIFIC CORP | EXIT | — | 0.0% | -3.9% | 0.0 | 0 | -299,318 | 0 | — |
| ☆CUSIP:880881107 funds › | TERNS PHARMACEUTICALS INC | EXIT | — | 0.0% | -4.5% | 0.0 | 0 | -409,031 | 0 | — |
| ☆QURE funds › | UNIQURE NV | EXIT | — | 0.0% | -1.7% | 0.0 | 0 | -491,116 | 0 | — |
| ☆ABVX funds › | ABIVAX SA | EXIT | — | 0.0% | -1.1% | 0.0 | 0 | -47,193 | 0 | — |
| ☆SUPN funds › | SUPERNUS PHARMACEUTICALS | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -62,019 | 0 | — |
| ☆ADPT funds › | ADAPTIVE BIOTECHNOLOGIES COR | EXIT | — | 0.0% | -2.1% | 0.0 | 0 | -722,784 | 0 | — |
| ☆CUSIP:04351P101 funds › | ASCENDIS PHARMA A/S | EXIT | — | 0.0% | -6.2% | 0.0 | 0 | -129,111 | 0 | — |
| ☆TYRA funds › | TYRA BIOSCIENCES INC | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -67,285 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 532 | 39 | 0.45 | 57% | 0.045 | 0.062 | — | in |
| 2026Q1 | 479 | 41 | 0.43 | 54% | 0.043 | 0.072 | — | in |
| 2025Q4 | 566 | 45 | 0.39 | 51% | 0.037 | 0.071 | — | in |
| 2025Q3 | 541 | 38 | 0.35 | 56% | 0.044 | 0.116 | — | in |
| 2025Q2 | 477 | 40 | 0.44 | 63% | 0.051 | 0.081 | — | entered |
| 2025Q1 | 403 | 35 | 0.00 | 70% | 0.060 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status